Steffi De Meyer

422 total citations
17 papers, 233 citations indexed

About

Steffi De Meyer is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Steffi De Meyer has authored 17 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Steffi De Meyer's work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (11 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Steffi De Meyer is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (11 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Steffi De Meyer collaborates with scholars based in Belgium, United States and Netherlands. Steffi De Meyer's co-authors include Rik Vandenberghe, Jolien Schaeverbeke, Emma S. Luckett, Koen Poesen, Koen Van Laere, Katarzyna Adamczuk, Patrick Dupont, Maxim De Schaepdryver, Silvy Gabel and Charlotte E. Teunissen and has published in prestigious journals such as Brain, European Journal of Nuclear Medicine and Molecular Imaging and Alzheimer s & Dementia.

In The Last Decade

Steffi De Meyer

17 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffi De Meyer Belgium 9 148 124 58 50 44 17 233
Natalia Ermann Germany 5 187 1.3× 134 1.1× 79 1.4× 78 1.6× 57 1.3× 6 299
Leila Sellami Canada 9 74 0.5× 83 0.7× 51 0.9× 70 1.4× 28 0.6× 21 211
Assunta Ingannato Italy 9 117 0.8× 111 0.9× 62 1.1× 49 1.0× 42 1.0× 32 289
Jonathan Vöglein Germany 9 95 0.6× 62 0.5× 40 0.7× 29 0.6× 21 0.5× 19 216
Julia Remnestål Sweden 7 112 0.8× 54 0.4× 83 1.4× 37 0.7× 21 0.5× 9 188
Hironobu Endo Japan 10 138 0.9× 75 0.6× 44 0.8× 101 2.0× 28 0.6× 28 268
Liyong Wu China 12 97 0.7× 63 0.5× 126 2.2× 41 0.8× 50 1.1× 39 295
Daniel J. Figdore United States 8 112 0.8× 109 0.9× 37 0.6× 29 0.6× 17 0.4× 17 213
Jean C. Cruz Hernández United States 5 137 0.9× 47 0.4× 48 0.8× 110 2.2× 83 1.9× 7 274
Karri Kaivola Finland 10 90 0.6× 42 0.3× 58 1.0× 151 3.0× 74 1.7× 16 261

Countries citing papers authored by Steffi De Meyer

Since Specialization
Citations

This map shows the geographic impact of Steffi De Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffi De Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffi De Meyer more than expected).

Fields of papers citing papers by Steffi De Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffi De Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffi De Meyer. The network helps show where Steffi De Meyer may publish in the future.

Co-authorship network of co-authors of Steffi De Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Steffi De Meyer. A scholar is included among the top collaborators of Steffi De Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffi De Meyer. Steffi De Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Meyer, Steffi De, Jolien Schaeverbeke, Katarzyna Adamczuk, et al.. (2025). Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70071–e70071. 2 indexed citations
2.
Meyer, Steffi De, Julie Goossens, Jeroen Vanbrabant, et al.. (2025). Plasma vesicle-associated membrane protein 2 and glial fibrillary acidic protein associate with synaptic density in older adults without dementia. Brain Communications. 7(4). fcaf207–fcaf207. 1 indexed citations
3.
Meyer, Steffi De, Jolien Schaeverbeke, Emma S. Luckett, et al.. (2024). Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET. Brain Communications. 6(4). fcae162–fcae162. 9 indexed citations
4.
François, Olivier, Senna Staessens, Liesbeth Desender, et al.. (2023). PB1220 DNase-1 Overcomes Thrombolytic rT-PA Resistance of Platelet-Rich Ischemic Stroke Thrombi. Research and Practice in Thrombosis and Haemostasis. 7. 101041–101041. 1 indexed citations
5.
Vanbrabant, Jeroen, Steffi De Meyer, Carrie E. Rubel, et al.. (2023). Performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays. Alzheimer s & Dementia. 19(S15). 1 indexed citations
6.
Luckett, Emma S., Jolien Schaeverbeke, Katarzyna Adamczuk, et al.. (2023). Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults. Alzheimer s Research & Therapy. 15(1). 121–121. 10 indexed citations
7.
Meyer, Steffi De, Jolien Schaeverbeke, Mariska Reinartz, et al.. (2023). Serum biomarkers for prognosis and monitoring in asymptomatic Alzheimer’s Disease. Alzheimer s & Dementia. 19(S14). 1 indexed citations
8.
Meyer, Steffi De, Jolien Schaeverbeke, Mariska Reinartz, et al.. (2023). Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes. Brain. 147(3). 936–948. 19 indexed citations
9.
Luckett, Emma S., Jolien Schaeverbeke, Steffi De Meyer, et al.. (2023). Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations. NeuroImage Clinical. 37. 103321–103321. 3 indexed citations
10.
Luckett, Emma S., Mariska Reinartz, Katarzyna Adamczuk, et al.. (2022). Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults. Alzheimer s Research & Therapy. 14(1). 138–138. 9 indexed citations
11.
Reinartz, Mariska, Emma S. Luckett, Jolien Schaeverbeke, et al.. (2022). Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3772–3786. 6 indexed citations
12.
Schaeverbeke, Jolien, Emma S. Luckett, Silvy Gabel, et al.. (2022). Lack of association between bridging integrator 1 ( BIN1 ) rs744373 polymorphism and tau‐PET load in cognitively intact older adults. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12227–e12227. 3 indexed citations
13.
Meyer, Steffi De, Jeroen Vanbrabant, Jolien Schaeverbeke, et al.. (2022). Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease. Annals of Clinical and Translational Neurology. 9(5). 734–746. 22 indexed citations
14.
Reinartz, Mariska, Silvy Gabel, Jolien Schaeverbeke, et al.. (2021). Changes in the language system as amyloid-β accumulates. Brain. 144(12). 3756–3768. 13 indexed citations
15.
Schaeverbeke, Jolien, Silvy Gabel, Karen Meersmans, et al.. (2021). Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Alzheimer s Research & Therapy. 13(1). 75–75. 28 indexed citations
16.
Meyer, Steffi De, Jolien Schaeverbeke, Inge M.W. Verberk, et al.. (2020). Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis. Alzheimer s Research & Therapy. 12(1). 162–162. 70 indexed citations
17.
Schaepdryver, Maxim De, Steffi De Meyer, Andreas Jeromin, et al.. (2019). Serum neurofilament heavy chains as early marker of motor neuron degeneration. Annals of Clinical and Translational Neurology. 6(10). 1971–1979. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Ermann Breakdown of academic impact, for papers by Leila Sellami Breakdown of academic impact, for papers by Assunta Ingannato Breakdown of academic impact, for papers by Jonathan Vöglein Breakdown of academic impact, for papers by Julia Remnestål Breakdown of academic impact, for papers by Hironobu Endo Breakdown of academic impact, for papers by Liyong Wu Breakdown of academic impact, for papers by Daniel J. Figdore Breakdown of academic impact, for papers by Jean C. Cruz Hernández Breakdown of academic impact, for papers by Karri Kaivola
Rankless by CCL
2026